Double trouble: Concomitant immune challenges result in CNS disease

A research team led by Glenn Rall at the Fox Chase Cancer Center in Philadelphia, PA developed a novel mouse model to show that a fatal central nervous system (CNS) disease can be caused by a pathogen that does not replicate in the CNS. The results of this new study are published December 22nd in the Open Access journal PLoS Pathogens.

The authors found that the immune response induced in response to a peripheral viral infection can be "mis-recruited" to the brain, where these activated can then lead to inflammation-induced and disease. While "mis-recruitment" has been observed in other mouse models, this is the first study to show that this phenomenon can have pathogenic consequences.

The novel model used two, tissue-restricted infections: lymphocytic choriomeningitis virus (LCMV), which, when injected intraperitoneally, is restricted to such as the liver, spleen and kidney, and measles virus (MV), which is limited to CNS neurons. While infection with either virus alone resulted in no mortality, co-infection caused CNS symptoms in all mice, and death in approximately half. The authors show that this was due to migration of peripherally activated LCMV-specific into the CNS, where they triggered edema leading to brain herniation, despite the apparent absence of LCMV antigens within the affected brain.

While the broader implications of this study await further investigation, this is a proof of principle study that addresses a key question: can a pathogen cause disease "at a distance"? Typically, we envision that diseases are manifested where infectious pathogens replicate: influenza causes respiratory infection because this is the primary site of replication. In contrast, this study suggests that infection can activate immune responses that can be deleterious in tissues that are not directly infected by the initiating pathogen. This may be of broader relevance to human CNS diseases of unknown etiology, including multiple sclerosis and amyotrophic lateral sclerosis.

The authors of this study point out, however, that "while making direct connections between this model system and human diseases would be premature, a similar phenomenon could account for both the reported increase in inflammatory cells found in the brain of patients, as well as the lack of consistent and convincing presence of any specific pathogen in the brains of affected individuals."

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Ebola death toll rises to 5,459: WHO

51 minutes ago

The World Health Organization said Friday that 5,459 people had so far died of Ebola out of a total 15,351 cases of infection in eight countries since late December 2013.

Flu season off to a slow start ... for now

3 hours ago

(HealthDay)—This year's flu season is off to a slow but detectable start. And it appears to be a typical one that's likely to peak in January or February, a leading U.S. health official says.

Update on new treatments for liver diseases

4 hours ago

Cirrhosis and nonalcoholic fatty liver disease (NAFLD) are two serious liver conditions with limited pharmacological treatments. The December issues of AGA's journals—Clinical Gastroenterology and Hepatology and Gastro ...

Amateur photographers aid in remote skin sore trial

5 hours ago

Paediatric infectious disease specialists are bringing novel skin sore research methods to WA in the form of a protocol allowing non-professional photographers to capture high-quality images of skin sores ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.